Herbsleb Malene, Birkenkamp-Demtroder Karin, Thykjaer Thomas, Wiuf Carsten, Hein Anne-Mette K, Orntoft Torben F, Dyrskjøt Lars
Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, DK-8200 Aarhus N, Denmark.
BMC Med Genomics. 2008 Jul 22;1:31. doi: 10.1186/1755-8794-1-31.
Mechanisms underlying the malignant development in bladder cancer are still not well understood. Lipolysis stimulated lipoprotein receptor (LSR) has previously been found to be upregulated by P53. Furthermore, we have previously found LSR to be differentially expressed in bladder cancer. Here we investigated the role of LSR in bladder cancer.
A time course siRNA knock down experiment was performed to investigate the functional role of LSR in SW780 bladder cancer cells. Since LSR was previously shown to be regulated by P53, siRNA against TP53 was included in the experimental setup. We used Affymetrix GeneChips for measuring gene expression changes and we used Ingenuity Pathway Analysis to investigate the relationship among differentially expressed genes upon siRNA knockdown.
By Ingenuity Pathway analysis of the microarray data from the different timepoints we identified six gene networks containing genes mainly related to the functional categories "cancer", "cell death", and "cellular movement". We determined that genes annotated to the functional category "cellular movement" including "invasion" and "cell motility" were highly significantly overrepresented. A matrigel assay showed that 24 h after transfection the invasion capacity was significantly increased 3-fold (p < 0.02) in LSR-siRNA transfected cells, and 2.7-fold (p < 0.02) in TP53-siRNA transfected cells compared to controls. After 48 h the motility capacity was significantly increased 3.5-fold (p < 0.004) in LSR-siRNA transfected cells, and 4.7-fold (p < 0.002) in TP53-siRNA transfected cells compared to controls.
We conclude that LSR may impair bladder cancer cells from gaining invasive properties.
膀胱癌恶性发展的潜在机制仍未完全明确。此前发现脂解刺激脂蛋白受体(LSR)受P53上调。此外,我们之前发现LSR在膀胱癌中存在差异表达。在此,我们研究了LSR在膀胱癌中的作用。
进行了一项时间进程siRNA敲低实验,以研究LSR在SW780膀胱癌细胞中的功能作用。由于之前显示LSR受P53调控,实验设置中包含了针对TP53的siRNA。我们使用Affymetrix基因芯片测量基因表达变化,并使用Ingenuity通路分析来研究siRNA敲低后差异表达基因之间的关系。
通过对不同时间点微阵列数据的Ingenuity通路分析,我们确定了六个基因网络,其中的基因主要与“癌症”“细胞死亡”和“细胞运动”功能类别相关。我们发现注释为“细胞运动”功能类别的基因,包括“侵袭”和“细胞迁移”,显著过度富集。基质胶侵袭实验表明,转染后24小时,与对照组相比,LSR-siRNA转染细胞的侵袭能力显著增加3倍(p < 0.02),TP53-siRNA转染细胞的侵袭能力增加2.7倍(p < 0.02)。48小时后,与对照组相比,LSR-siRNA转染细胞的迁移能力显著增加3.5倍(p < 0.004),TP53-siRNA转染细胞的迁移能力增加4.7倍(p < 0.002)。
我们得出结论,LSR可能会抑制膀胱癌细胞获得侵袭特性。